Bright Minds Biosciences Inc (DRUG) - News Archive

Showing 2 of 2 results.

Bright Minds Biosciences Seeks Redemption with $35 Million Fundraising Amidst Financial Turmoil and Competitive Pressure,

Bright Minds Biosciences: A $35 Million Gamble Amidst Dismal Financials and Industry CompetitionIn an audacious move that has raised eyebrows among investors and market analysts alike, Bright Minds Biosciences Inc. (CSE...

Nov 4, 2024 • Major Pharmaceutical Preparations Industry Management Announcement

BMB-201 A New Hope in Pain Management Amidst Financial Struggles

In the fast-paced world of pharmaceutical innovation, Bright Minds Biosciences Inc. stands at a crucial juncture as it unveils promising data on its proprietary compound, BMB-201. This mixed agonist of the 5-HT2C and 5-...

Oct 16, 2024 • Major Pharmaceutical Preparations Industry Clinical Study NASDAQ: DRUGPerceptive Advisors L Bright Minds Bio